Behaviour-change intervention in a multicentre, randomised, placebocontrolled COPD study: Methodological considerations and implementation

BMJ Open

Volumn 6, Issue 4, 2016, Pages

  Bourbeau, Jean ^a   Lavoie, Kim L ^b,c   Sedeno, Maria ^a   De Sousa, Dorothy ^d   Erzen, Damijan ^e   Hamilton, Alan ^d   Maltais, François ^f   Troosters, Thierry ^g   Leidy, Nancy ^h  

^a Respiratory Epidemiology and Clinical Research Unit   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^e BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^f LAVAL UNIVERSITY   (Canada)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h EVIDERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLODATEROL; TIOTROPIUM BROMIDE; BENZOXAZINE DERIVATIVE; BRONCHODILATING AGENT;

ARTICLE; BEHAVIOR CHANGE; BIOETHICS; CASE MANAGER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; EXERCISE; HEALTH CARE DELIVERY; HUMAN; INFORMATION DISSEMINATION; MAINTENANCE THERAPY; MULTICENTER STUDY; PATIENT EDUCATION; PHASE 3 CLINICAL TRIAL; PHYSICAL ACTIVITY; PROGRAM EVALUATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SOFT MIST INHALER; STUDY DESIGN; ADULT; AGED; AUSTRALIA; CANADA; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EUROPE; EXERCISE TEST; FEMALE; KINESIOTHERAPY; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEW ZEALAND; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED STATES; WALKING;

ADULT; AGED; AUSTRALIA; BENZOXAZINES; BRONCHODILATOR AGENTS; CANADA; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; EUROPE; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESEARCH DESIGN; SELF CARE; TIOTROPIUM BROMIDE; TREATMENT OUTCOME; UNITED STATES; WALKING;

EID: 84969945227     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010109     Document Type: Article

References (38)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. 2015. http://www.goldcopd.org/uploads/users/files/GOLD-Report-2015-Feb18.pdf (accessed 1 Jul 2015).
2. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972-7.
3. Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010;104:1005-11.
4. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med 2006;119:32-7.
5. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest 2006;129:536-44.
6. Garcia-Aymerich J, Serra I, Gómez FP, et al. Physical activity and clinical and functional status in COPD. Chest 2009;136:62-70.
7. Vaes AW, Garcia-Aymerich J, Marott JL, et al. Changes in physical activity and all-cause mortality in COPD. Eur Respir J 2014;44:1199-209.
8. Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J 2014;44:1521-37.
9. Maltais F, Mahler DA, Pepin V, et al. Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD. Eur Respir J 2013;42:539-41.
10. Maltais F, Gáldiz Iturri JB, Kirsten A, et al. Effects of 12 weeks of once-daily tiotropium and olodaterol fixed-dose combination on exercise endurance in patients with COPD [abstract]. Eur Respir J 2014;44(Suppl 58):abs P283.
11. Maltais F, Singh S, Donald A, et al. Effects of a combination of vilanterol and umeclidinium on exercise endurance in subjects with COPD: Two randomised clinical trials [abstract]. Eur Respir J 2013;42(Suppl 57):abs P761.
12. Maltais F, Kirsten A-M, Hamilton A, et al. Evaluation of the effects of olodaterol on exercise endurance in patients with COPD: results from two 6-week studies [abstract]. Chest 2013;144(No.4 Meeting Abstracts):abs 748A.
13. Pitta F, Troosters T, Probst VS, et al. Are patients with COPD more active after pulmonary rehabilitation? Chest 2008;134:273-80.
14. Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modification in COPD. Patient Educ Couns 2004;52:271-7.
15. Glanz K, Rimer BK, Viswanath K, eds. Health behavior and health education. Theory, research, and practice. 4th edn. San Francisco, CA: John Wiley & Sons, Inc., 2008.
16. Rouleau CR, Lavoie KL, Bacon SL, et al. Training healthcare providers in motivational communication for promoting physical activity and exercise in cardiometabolic health settings: do we know what we are doing? Curr Cardiovasc Risk Rep 2015;9:29.
17. Leidy NK, Kimel M, Ajagbe L, et al. Designing trials of behavioral interventions to increase physical activity in patients with COPD: insights from the chronic disease literature. Respir Med 2014;108:472-81.
18. Rutledge T, Redwine LS, Linke SE, et al. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 2013;75:335-49.
19. Lavoie KL, Campbell TS, Bacon SL. Behavioral medicine trial design: Time for a change. Arch Intern Med 2012;172:1350-1.
20. Troosters T, Bourbeau J, Maltais F, et al. Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design. BMJ Open 2016;6:e010106.
21. Leidy NK, Knebel A. In search of parsimony: reliability and validity of the Functional Performance Inventory-Short Form. Int J Chron Obstruct Pulmon Dis 2010;5:415-23.
22. Leidy NK, Hamilton A, Becker K. Assessing patient report of function: content validity of the Functional Performance Inventory-Short Form (FPI-SF) in patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis 2012;7:543-54.
23. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9.
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
25. Spitzer RL, Kroenke K, Williams JBW, et al. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA 1999;282:1737-44.
26. Spitzer RL, Williams JBW, Kroenke K, et al. Validity and utility of the PRIME-MD Patient Health Questionnaire in assessment of 3000 obstetric-gynecologic patients: The PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 2000;183:759-69.
27. Living Well with COPD™. 2015. http://www.livingwellwithcopd.com/en/home.html (accessed 12 Jan 2015).
28. Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care. Helping patients change behavior. New York, NY: The Guilford Press, 2008.
29. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-17.
30. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 2000;31:73-86.
31. Garber CE, Allsworth JE, Marcus BH, et al. Correlates of the stages of change for physical activity in a population survey. Am J Public Health 2008;98:897-904.
32. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
33. Levesque CS, Williams GC, Elliot D, et al. Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Health Educ Res 2007;22:691-702.
34. Williams GC, Freedman ZR, Deci EL. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care 1998;21:1644-51.
35. Chan AW, Tetzlaff JM, Gotzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586.
36. Bourbeau J. Making pulmonary rehabilitation a success in COPD. Swiss Med Wkly 2010;140:w13067.
37. Bourbeau J. The role of collaborative self-management in pulmonary rehabilitation. Semin Respir Crit Care Med 2009;30:700-7.
38. Bacon SL, Lavoie KL, Ninot G, et al. An international perspective on improving the quality and potential of behavioral clinical trials. Curr Cardiovasc Risk Rep 2015;9:427.